Patents/Assignees

Q32 Bio Inc.

1 patent in portfolio

US11879008utility2024
Methods of Treating Complement Mediated Diseases with Fusion Protein Constructs Comprising Anti-c3d Antibody and a Complement Modulator
0 cites